Class I · Most seriousActive recall
Rheumacare capsules
A reasonable chance it could cause serious harm or death.
Does this affect you?
Check your lot numberLot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028
Where it was soldProduct was distributed to one customer in NY.
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
CGMP Deviations: product found to contain lead.
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
| Distributed by / for | HANDELNINE GLOBAL LLC |
Show the full FDA record
| Full product label | Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313 |
| Recalling firm | HANDELNINE GLOBAL LLC |
| Distribution | Product was distributed to one customer in NY. |
| Quantity | 4 bottles /30 capsules each |
| Recall initiated | 2025-12-22 |
| Report date | 2026-02-11 |
| Recall completed | — |
| Recall number | D-0332-2026 |
| Classification | Class I |
| FDA status | Ongoing |
| Origin on file | South Plainfield NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.